Search results
Pfizer confirms COVID pill's results, potency versus omicron
AOL· 5 days agoPfizer said Tuesday that its experimental COVID-19 pill appears effective against the omicron...
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
NBC Universal via AOL· 4 days agoThe Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding...
FDA grants full approval to cervical cancer drug TIVDAK By Investing.com
Investing.com· 1 day agoNEW YORK & COPENHAGEN - Pfizer Inc. (NYSE: NYSE:PFE) and Genmab A/S (NASDAQ: NASDAQ:GMAB) have...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 4 days agoThe Food and Drug Administration approved Pfizer's hemophilia B gene therapy on Friday, a one-time...
Pfizer’s First Gene Therapy Gets Approval for Clotting Disorder
Bloomberg· 5 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 6 days agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
S&P 500 futures fall as Wall Street braces for Fed rate decision: Live updates
CNBC· 3 hours agoS&P 500 futures slipped Tuesday night as investors looked ahead to the Federal Reserve's rate policy...
First trial over Zantac cancer claims set to begin in Chicago
Reuters· 5 hours ago, opens new tab and other companies, causes cancer is set to begin this week in Chicago. Jury...
Forget Nvidia: Prominent Billionaires Are Selling It and Buying These 2 Ultra-High-Yield Dividend...
Motley Fool via Yahoo Finance· 16 hours agoGiven that wireless access and broadband service have evolved into necessities, there's not much...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 1 day agoCOPENHAGEN, Denmark; April 30, 2024 – Genmab A/S (Nasdaq: GMAB) and Pfizer Inc. (NYSE: PFE) announced today the U.S. Food and Drug Administration (FDA) has approved the supplemental ...